Is AbbVie Stock a Buy? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
spent roughly $9 billion to acquire the rights to failed its clinical trials. Investors are also on edge over how the Trump administration and new Secretary of Health and Human Services Robert F. Kennedy Jr. might treat AbbVie and other U.S. pharmaceutical companies. AbbVie bounced back after strong fourth-quarter results, but tariff fears and market volatility have sent shares tumbling again. Today, AbbVie's stock sits roughly 20% off its highs. It's a good time to take a breather, assess the underlying business, and consider whether the stock's decline offers enough value to make AbbVie a buy despite all this noise. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Here is what you need to know. If you've followed AbbVie in the past, it spent years reaping the windfall of Humira, an immunology drug used to treat various conditions, including rheumatoid arthritis and plaque psoriasis. It was
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott increases quarterly dividend for 54th consecutive year [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories raises dividend by ~7% [Seeking Alpha]Seeking Alpha
- Abbott increases quarterly dividend for 54th consecutive yearPR Newswire
- Biotech Innovations Propel Infectious Disease Testing Forward [Yahoo! Finance]Yahoo! Finance
- Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose DataPR Newswire
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 12/12/25 - Form 4
- 12/12/25 - Form 8-K
- 12/3/25 - Form SCHEDULE
- ABT's page on the SEC website